Background
Early disease detection is fundamental to improving clinical outcomes, reducing healthcare costs, and enhancing patient survival. Traditional diagnostic approaches often rely on symptom presentation and clinician interpretation, which may delay diagnosis. Machine Learning (ML), a subset of Artificial Intelligence (AI), has emerged as a transformative tool capable of identifying disease patterns from large and complex healthcare datasets. ML algorithms can support early detection of chronic diseases, cancers, cardiovascular conditions, infectious diseases, and neurological disorders.
Objective
To evaluate the applications of machine learning in early disease detection and assess its impact on diagnostic accuracy, clinical decision-making, patient outcomes, and healthcare delivery.
Methods
A narrative review and observational analytical framework were developed using published literature, clinical case studies, and healthcare data models. Major machine learning applications across oncology, cardiology, neurology, radiology, pathology, and infectious disease surveillance were analyzed. Outcomes included diagnostic accuracy, sensitivity, specificity, predictive performance, and implementation challenges.
Results
Machine learning models demonstrated high diagnostic accuracy across multiple disease categories. Deep learning-based imaging systems achieved sensitivity rates exceeding 90% in cancer detection, diabetic retinopathy screening, and cardiovascular risk prediction. Predictive analytics improved early disease identification and enabled proactive clinical interventions. Challenges included data quality, algorithm bias, interpretability, privacy concerns, and integration into clinical workflows.
Conclusion
Machine learning has significant potential to transform early disease detection by enabling predictive, personalized, and data-driven healthcare. Successful implementation requires robust validation, ethical governance, transparent algorithms, and clinician involvement to maximize patient benefit.